These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30914272)

  • 41. Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques.
    Hamrang Z; Hussain M; Tingey K; Tracka M; Casas-Finet JR; Uddin S; van der Walle CF; Pluen A
    J Pharm Sci; 2015 Aug; 104(8):2473-81. PubMed ID: 26053418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variables Impacting Silicone Oil Migration and Biologics in Prefilled Syringes.
    Gentile K; Huang C; Liu X; Whitty-Léveillé L; Hamzaoui H; Cristofolli E; Rayfield W; Afanador NL; Mittal S; Krishnamachari Y; Xi H; Zhao X
    J Pharm Sci; 2023 Aug; 112(8):2203-2211. PubMed ID: 37244516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silicone-oil-based subvisible particles: their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals.
    Felsovalyi F; Janvier S; Jouffray S; Soukiassian H; Mangiagalli P
    J Pharm Sci; 2012 Dec; 101(12):4569-83. PubMed ID: 23023774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Method to Determine Syringe Silicone Oil Layer Heterogeneity and Investigation of its Impact on Product Particle Counts.
    Cua M; Martin D; Meza P; Torraca G; Pearson T; Cao S; Yang C
    J Pharm Sci; 2020 Nov; 109(11):3292-3299. PubMed ID: 32679217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Micro-flow imaging and resonant mass measurement (Archimedes)--complementary methods to quantitatively differentiate protein particles and silicone oil droplets.
    Weinbuch D; Zölls S; Wiggenhorn M; Friess W; Winter G; Jiskoot W; Hawe A
    J Pharm Sci; 2013 Jul; 102(7):2152-65. PubMed ID: 23625851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of Average Aggregate Density by Sedimentation and Brownian Motion Analysis.
    Cavicchi RE; King J; Ripple DC
    J Pharm Sci; 2018 May; 107(5):1304-1312. PubMed ID: 29409841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Taking Subvisible Particle Quantitation to the Limit: Uncertainties and Statistical Challenges With Ophthalmic Products for Intravitreal Injection.
    Gühlke M; Hecht J; Böhrer A; Hawe A; Nikels F; Garidel P; Menzen T
    J Pharm Sci; 2020 Jan; 109(1):505-514. PubMed ID: 31682829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab.
    Schargus M; Kopp KT; Helbig C; Frings A; Winter G
    Transl Vis Sci Technol; 2021 Aug; 10(9):21. PubMed ID: 34406342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.
    Kalonia C; Kumru OS; Prajapati I; Mathaes R; Engert J; Zhou S; Middaugh CR; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):536-47. PubMed ID: 25302696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Silicone Oil on Free Fatty Acid Particle Formation due to Polysorbate 20 Degradation.
    Fish R; Lin J; Doshi N
    Pharm Res; 2020 Oct; 37(11):216. PubMed ID: 33029664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
    Corvari V; Narhi LO; Spitznagel TM; Afonina N; Cao S; Cash P; Cecchini I; DeFelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Weiskopf A; Wuchner K
    Biologicals; 2015 Nov; 43(6):457-73. PubMed ID: 26324466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adsorption and Aggregation of Monoclonal Antibodies at Silicone Oil-Water Interfaces.
    Kannan A; Shieh IC; Negulescu PG; Chandran Suja V; Fuller GG
    Mol Pharm; 2021 Apr; 18(4):1656-1665. PubMed ID: 33656340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discrimination between silicone oil droplets and protein aggregates in biopharmaceuticals: a novel multiparametric image filter for sub-visible particles in microflow imaging analysis.
    Strehl R; Rombach-Riegraf V; Diez M; Egodage K; Bluemel M; Jeschke M; Koulov AV
    Pharm Res; 2012 Feb; 29(2):594-602. PubMed ID: 21948455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Product Handling Parameters on Particle Levels in a Commercial Factor VIII Product: Impacts and Mitigation.
    Ueda T; Nakamura K; Abe Y; Carpenter JF
    J Pharm Sci; 2019 Jan; 108(1):775-786. PubMed ID: 30196040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Applying Pattern Recognition as a Robust Approach for Silicone Oil Droplet Identification in Flow-Microscopy Images of Protein Formulations.
    Chen XG; Graužinytė M; van der Vaart AW; Boll B
    J Pharm Sci; 2021 Apr; 110(4):1643-1651. PubMed ID: 33122049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards quantification and differentiation of protein aggregates and silicone oil droplets in the low micrometer and submicrometer size range by using oil-immersion flow imaging microscopy and convolutional neural networks.
    Umar M; Krause N; Hawe A; Simmel F; Menzen T
    Eur J Pharm Biopharm; 2021 Dec; 169():97-102. PubMed ID: 34597817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional evaluation and characterization of a newly developed silicone oil-free prefillable syringe system.
    Yoshino K; Nakamura K; Yamashita A; Abe Y; Iwasaki K; Kanazawa Y; Funatsu K; Yoshimoto T; Suzuki S
    J Pharm Sci; 2014 May; 103(5):1520-8. PubMed ID: 24643749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
    Nayak A; Colandene J; Bradford V; Perkins M
    J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation of subvisible silicone oil droplets from irregular standard dust particles.
    Vandesteeg N; Kilbert C
    J Pharm Sci; 2013 Jun; 102(6):1696-1700. PubMed ID: 23595940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.